1997
DOI: 10.1016/s0169-5002(97)83913-x
|View full text |Cite
|
Sign up to set email alerts
|

Induction of p53ras specific cellular immunity in patients with common solid tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 0 publications
1
8
0
Order By: Relevance
“…DC infiltrated into tumor tissue showed a reduced expression of co-stimulatory molecules, defective cytokine production, and full allostimulatory activity, implying that tumor-derived factors impede DC maturation. 28,29) These effects appear to be maturation-dependent, acting only on DC precursors and not mature DC. Therefore, it may be better to use mature DC for clinical use.…”
Section: Discussionmentioning
confidence: 99%
“…DC infiltrated into tumor tissue showed a reduced expression of co-stimulatory molecules, defective cytokine production, and full allostimulatory activity, implying that tumor-derived factors impede DC maturation. 28,29) These effects appear to be maturation-dependent, acting only on DC precursors and not mature DC. Therefore, it may be better to use mature DC for clinical use.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] DC activate both naive and memory CD4 Ï© and CD8 Ï© T cells [35][36][37] and seem to meet all requirements as a strong immune-activator for anti-tumor immunity or immunity against microbial infection. [38][39][40] Located in most host tissues, DC function as immune sentinels for infectious agents and inflammatory products of bacteria. Immature DC can capture antigens in peripheral tissues and undergo maturation processes to stimulate naive T cells in secondary lymphoid organs.…”
Section: Pl Is Involved With Erk P38 Kinases and Nf-k Kb P65mentioning
confidence: 99%
“…Tumours have the capacity to limit APC maturation, function and infiltration of the tumour site [27–30]. Thus the molecules that attract host APCs and T‐ cells could serve as potent agents for cancer immunotherapy.…”
Section: Discussionmentioning
confidence: 99%